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The long-range goal of the windows to the brain (WttB) is to improve patient care by providing a technique for delivery and/or collection
of light into/from the brain, on demand, over large areas, and on a chronically-recurring basis without the need for repeated craniotomies. To
evaluate the potential of nanocrystalline yttria-stabilized-zirconia (nc-YSZ) cranial implant for optical therapy and imaging, in vivo
biocompatibility was studied using the dorsal window chamber model in comparison with control (no implant) and commercially available
cranial implant materials (PEEK and PEKK). The host tissue response to implant was characterized by using transillumination and
fluorescent microscopy to measure leukocyte adhesion, blood vessel diameter, blood flow rate, and vascular permeability over two weeks.
The results indicated the lack of inflammatory reaction of the host tissue to nc-YSZ at the microscopic level, suggesting that nc-YSZ is a
good alternative material for cranial implants.
© 2016 Elsevier Inc. All rights reserved.
Key words: Windows to the brain; Yttria-stabilized-zirconia; Cranial implant; Dorsal window chamber modelCraniotomy is an established procedure in neurosurgery to
decrease intracranial pressure after brain infarction, intracranial
hemorrhage, and brain traumatic injury resulting from cerebral
edema. During this procedure parts of the brain become exposed,
leaving it unprotected and giving the patient a malformed
appearance. Cranioplasty is the subsequent surgical procedure to
restore the aesthetic appearance of the cranium and provide the
necessary mechanical protection to the brain. A successful
cranioplasty has shown to improve electroencephalographic
abnormalities, cerebral blood flow abnormalities, and other
neurological abnormalities.1-3 The ideal material used for cranio-
plasty needs to be 1) radiolucent, 2) resistant to infections, 3) thermal
insulator, 4) resistant to mechanical load, 5) malleable to fit defects
with complete closure, and ideally, 6) inexpensive.4 Over time, a
broad spectrum of synthetic materials has been used for
cranioplasty,5 including titanium and PEEK (poly-ether-ether
ketone).6,7 A new thermoplastic matrix system PEKK (poly-ether-⁎Corresponding author at: Department of Mechanical Engineering,
University of California Riverside, Riverside, CA, USA.
http://dx.doi.org/10.1016/j.nano.2016.04.009
1549-9634/© 2016 Elsevier Inc. All rights reserved.ketone-ketone), resembles bonemore so than titanium.8,9 PEEK and
PEKK are more elastic and are less dense which pose some
advantages, whereas titanium has a higher yield and ultimate
strength, making it mechanically more stable.10 PEKK has higher
compressive strength than PEEK and has demonstrated to have
superior performance in mechanical properties, fracture toughness
and damage tolerance.11,12
All these materials seem appropriate to protect the brain against
mechanical trauma. However, these polymers do not provide the
requisite combination of properties required for clinically-viable
transparent implants. During the past few years, researchers have
been working on several promising options to circumvent the
limitations of currentmaterials for cranial reconstruction.5 Our group
has aimed to develop a novel transparent ceramicmaterial capable of
providing access to the brain for imaging and therapeutic purposes.13
This material is nanocrystalline yttria-stabilized-zirconia (nc-YSZ),
and it is synthesized by a relatively new densification process
known as current activated pressure assisted densification
(CAPAD) technique.14,15 YSZ produced using conventional
ceramic processing methods is typically opaque, due to scattering
induced by micrometer-scale (and larger) internal porosity.16
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nanometric dimensions. At this length scale, porosity is sufficiently
small to minimize scattering in the spectral range of interest for
laser-based diagnostics and therapeutics.16
Nc-YSZ implants will provide a combination of transparency,
toughness, and biocompatibility to support angiogenesis, and
neovascularization, for clinically-viable transparent cranial
implants.10,17 The dorsal window chamber model (DWCM) is
widely used to chronically study the intact microcirculation.18
DWCM allows for the in vivo analysis of biocompatibility, as it
allows long-term quantification of hemodynamic, angiogenic,
and inflammatory response for several weeks after material
implantation.19 DWCM has been previously used to study the
biocompatibility of ceramic, and titanium.20-22
The objective of the study is to quantify hemodynamic and
inflammatory changes resulting from implantation of nc-YSZ,
PEEK, and PEKK in the DWCM. The study tests the hypothesis
that the biocompatibility of nc-YSZ is superior to currently used
material for cranioplasty, PEEK and PEKK. Biocompatibility is
assessed in our study in terms of hemodynamics, vascular
permeability, and leukocyte activation.Materials and methods
Animal model and implantation
Animal handling and carewere provided following the Care and
Use of Laboratory Animals.23 All animal experiments were
conducted under a protocol approved by the University of
California, San Diego Institutional Animal Care and Use
Committee (S04052, Microhemodynamics of Hamster Skinfold
Model, approved on 04/04/2015). Male golden Syrian hamsters of
50-70 gwere fittedwith a one-sidedwindowchamber consisting of
two titanium supports, one of which holds a 12-mm-diameter glass
window. The complete surgical technique was reported
previously.24,25 Briefly, the animals were prepared for chamber
implantation with a long acting anesthetic, sodium pentobarbital
(i.p. 50 mg/kg).24 After hair removal, two sutures were used to
lift the dorsal skin of the back away from the animal and one frame
of the chamber was positioned on the animal’s back. With the aid
of backlighting and a stereomicroscope, following the outline of
the window, skin was removed until only a thin monolayer of
retractor muscle and the intact subcutaneous skin of the opposing
side remained.
Implantation
Asmall square of 2 by 2 mmwith a thickness of 100 μmwas cut
and sterilized prior to implantation. Nc-YSZ (fabricated byCAPAD
technique),15 PEEK (McMaster-Carr, Los Angeles, CA), and
PEKK (Oxford Performance Materials, South Windsor, CT) were
placed directly onto the striated muscle and subcutaneous tissue
under the cover slip (Figure 1).During implantation, a drop of saline
solution was used to hold the sample in place between the exposed
skin and the frame of the chamber. Stainless steel nuts between the
frames were used as spacers (450 to 500 μm). The animal was
allowed to rest for 2 days, at which time its chamber was evaluated
under the microscope (650×) for any sign of infection, edema, orbleeding. Animals absent of any microvascular complication were
anesthetized again with sodium pentobarbital and arterial and
venous catheters (PE-50) in the carotid artery and jugular vein were
implanted, respectively. Catheters were filled with heparinized
saline (40 IU/ml), to ensure patency. Catheters were tunneled under
the skin and exteriorized at the dorsal side of the neck where they
were attached to the chamber frame.
Inclusion criteria
Hamsters were suitable for the experiments if: 1) systemic
parameters were within normal range. Namely, heart rate (HR)
N350 beat/min, mean arterial blood pressure (MAP) N80 mmHg,
systemic hematocrit (Hct) N45%, arterial PO2 pressure (PaO2)
N50 mmHg and arterial PCO2 pressure (PaCO2) N35 mmHg;
and 2) microscopic examination of the tissue in the chamber
observed under ×650 magnification did not reveal signs of edema
or bleeding. Hamsters are fossorial animals with a low arterial PO2
compared to other rodents; however, the PO2s in the window
chamber are similar to the PO2s in other rodents.
26
Experimental groups
Animals were assigned randomly to the different experimental
groups. Groups are labeled based on the material implanted. A
prior calculation of the sample size to evaluate changes in blood
flow after implantation in DWCM, suggested that blood flow after
one week implantation of nc-YSZ, presented a standard deviation
of 17% and expected difference from baseline of 130% (mean: 2.3
relative to baseline, and SD = 0.4 relative to baseline). Therefore,
the minimal number of experiments using a power analysis with
alpha of 0.05 and a 1-beta of 0.9 estimated 4 animals were required
to detect changes in blood flow from baseline. Accordingly, the
study includes four animals experimental group: 1) Control (n = 4,
without any implant); 2) nc-YSZ (n = 7); PEEK (n = 4); and
PEKK (n = 4). The additional animals in nc-YSZ were used to
develop the model.
Intravital microscopy experimental setup
The animals were restrained in a Plexiglas tube, which allows
the window chamber to protrude and be fixed to the microscope
stage. Observations were completed using transillumination
(BX51WI, Olympus, New Hyde Park, NY).
Measurements were carried out using a 40X (LUMPFL-WIR,
NA 0.8, Olympus) water immersion objective. Animals were given
10 to 15 min to adjust to the tube environment before any
measurement. Detailed mappings were made of the chamber
vasculature to follow the same vessels studied at baseline throughout
the experiment. Blood vesselswere chosen by a distinctive anatomic
landmark. Tissue was illuminated with a mercury arc lamp (100 W,
Walker Instruments, Scottsdale, AZ) and a 400 nm filter (Spectra
Physics, no. 59820). Images were recorded with a high speed video
camera (1000 × 1000 pixels, 2000 fps, Fastcam 1024 PCI, Photron,
San Diego, USA). Camera shutter speed was 1/10 of the frame rate.
Microhemodynamics
A video image-shearing method was used to measure vessel
diameter (D).27 This technique possesses a resolution of 1 μm for
vessels of 15-20 μm diameter and greater, and it measures the
Figure 1. (A) Photograph of dorsal skinfold chamber of Syrian golden hamsters, containing striated muscle and skin and allowing for repeated analysis of the
microcirculation in an awaken hamster for twoweeks. Here a nc-YSZ sample (*)was implanted. (B,C,D) Representative intravital fluorescencemicroscopy image of
the microcirculation under the nc-YSZ implant 15 days after implantation at 20× with: (B) white light; (C) green-light epi-illumination upon injection of Rhodamine
6G for direct labeling of activated leukocytes. (D) Blue-light epi-illumination upon injection of macromolecular fluorescent dye FITC-labeled Dextran.
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image files. Image sheering device is not subjective, as it is
based on the distance in pixels between edges of blood
vessels.27 Changes in arteriolar and venular diameter from
baseline were used as indicators of a change in vascular tone.
Arteriolar and venular centerline velocities were measured off-line
using the image cross-correlation method.28 This method was
selected over laser Doppler velocimetry as it allows for blood
flow measurements of specific blood vessels near the implanted
materials. The measured centerline velocity (V) was corrected
according to vessel size to obtain the mean RBC velocity.29
Blood flow (Q) was calculated from the measured values as
Q = π × V (D/2).2
Leukocyte endothelial interaction
To label leukocytes, animals received intravenous injection of
5 mg/kg of Rhodamine 6G (Sigma-Aldrich, St Louis) infused in a
volume equal to 0.1 mL. Fluorescently labeled leukocytes were
excited and images were captured with a Vivid Set (XF104-2 filter,
Omega Filters, Brattleboro, VT) using a low light camera (ORCA
9247, Hamamatsu, Tokyo, Japan). Briefly, a straight portion of
blood vessels was illuminated for 60 sec and video was recorded
(10 frames/s). Leukocytes were counted during video playback in a
100 μm length segment and categorized according to their flow
behaviour as “free-flowing”, “rolling” on the endothelium, and“immobilized” cells.30 The rolling leukocytes were white cells
rolling on the endothelium and reported as the percentage of all
leukocytes passing, “free-flowing”.
Macromolecule vascular permeability
Vascular permeability was studied after infusion in a volume
equal to 0.1 mL of an intravenous injection of 5 mg/kg fluorescein
isothiocyanate (FITC)-conjugated dextranwith amolecularweight of
150 kDa (FITC-dextran). Fluorescent macromolecular permeability
was studied by measuring the fluorescence intensities of the
perivascular and intravascular space for the blood vessels studied.
FITC-dextran fluorescence were excited and images were captured
with aVividSet (XF25 filter,OmegaFilters, Brattleboro,VT) using a
low light camera (ORCA 9247, Hamamatsu, Tokyo, Japan).
Fluorescence levels were measured using ImageJ (Java-based
image processing programdeveloped at theNIHbyWayneRasband,
http://rsb.info.nih.gov/ij/). Intensities of the perivascular space
directly adjacent to the blood vessel wall (E1) and intensity of the
intravascular space (E2), were used to estimate an extravasation index
(E), defined as E = E1/E2.
Microvascular experimental protocol
Awaken animals were restrained in a Plexiglas tube fromwhich
the window chamber protrudes and the restraining tube was fixed
to the intravital microscope stage. Hemodynamic measurements
Figure 2. Normalized arteriolar (A) and venular (B) diameter of dorsal
skinfold chamber of hamsters implanted with nc-YSZ, PEEK and PEKK in
comparison with control (no implant).
Figure 3. Normalized arteriolar (A) and venular (B) velocity of dorsal
skinfold chamber of hamsters implanted with nc-YSZ, PEEK and PEKK in
comparison with control (no implant). 2-way ANOVA repeated measures,
Bonferroni post-test *P b 0.05 relative to control.
1760 Y. Damestani et al / Nanomedicine: Nanotechnology, Biology, and Medicine 12 (2016) 1757–1763were made 2, 5, 7, 10, 12 and 15 days after material implantation.
Leukocyte endothelia interaction and macromolecule vascular
permeability were studied 15 days after material implantation.
Microhemodynamics, leukocyte-endothelial interaction, and
macromolecule permeability were assessed in different microvas-
cular regions of interest (ROI) including tissue behind the implant,
tissue surrounding the implant, and tissue far away from the
implant. In each ROI, six to eight arterioles and venules were
selected in each preparation. Fields of observation and vesselswere
chosen for study at locations in the tissue where the vessels were in
sharp focus. After 15 days, animals were euthanized.
Statistical analysis
Results are presented as mean ± standard error of the mean
(SEM). Hemodynamic results within each group were analyzed
using analysis of variance for repeated measurements (ANOVA,
Kruskal-Wallis test). When appropriate, post hoc analyses were
performed with the Dunn’s multiple comparison test. Hemody-
namic data comparison between groups was analyzed using
two-way analysis of variance (two-way ANOVA test). When
appropriate, post-test analyses were performed with the Bonferroni
post-tests comparison. Leukocytes adherent and rolling, and
vascular permeability of each groups were tested for normality
according to the Shapiro-Wilk test, and analyzed using analysis of
variance for repeated measurements (ANOVA, Brown-Forsythe
test).When appropriate, post hoc analyses were performedwith the
Bonferroni's multiple comparisons test. Microhemodynamic data
is presented normalized to day 2 after implantation. All statistics
were calculated using GraphPad Prism 5.01 (GraphPad Software,
Inc., San Diego, CA). Changes were considered statistically
significant if P b 0.05.Results
All animals completed the study protocol without visible sign
of discomfort. Animals were observed resting and periodically
eating throughout the experiment. In Figures 2-4, week 1
consisted of data collected on days 5 and 7, and week 2 consisted
of data collected on days 10, 12, and 15.
Microhemodynamics: Microvascular diameter
Diameter of a total number of 45 arterioles was investigated
(control, n = 8; nc-YSZ, n = 20, PEEK, n = 8, PEKK, n = 9,
where n corresponds to the number of microvessels study per
group). Range of inner diameter of baseline arterioles proved to
be similar in all groups (control, 34-68 μm; nc-YSZ, 36-84 μm;
PEEK, 39-68 μm; PEKK, 24-70 μm). No statistically significant
difference was observed in microvascular variables measured at
day 2 between groups. The results in Figure 2, A indicated that
the mean arterioles in animals in all four groups exhibited slight
vasodilation over two weeks (mean N1). However, the
vasodilation was not statistically significant for implants in
comparison with control in each week.
Diameter of a total number of 52 venules was investigated
(control, n = 12; nc-YSZ, n = 21; PEEK, n = 10; PEKK, n = 9).
Range of baseline venules was similar in all groups (control,
28-68 μm; nc-YSZ, 27-84 μm; PEEK, 32-68 μm; PEKK,
35-70 μm). The results in Figure 2, B reveal almost constant
venular diameters over time, withminor difference between groups.
Microhemodynamics: Microvascular velocity
The computed velocity profiles characterized by the velocity
of RBC and obtained from in vivo videos depict a parabolic
Figure 4. Normalized arteriolar (A) and venular (B) flow of dorsal skinfold
chamber of hamsters implanted with nc-YSZ, PEEK and PEKK in
comparison with control (no implant).
Figure 5. Number of rolling leukocytes (given in % of non-adherent
leukocytes) in venules of hamster dorsal skinfold 15 days after control (no
implant) and implantation of nc-YSZ, PEEK, PEKK. N = 20 for each
condition and error bars represent 1 standard deviation.
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Velocity of a total of 39 arterioles was investigated for two weeks
(control, n = 20; nc-YSZ, n = 7; PEEK, n = 6; PEKK, n = 6).
Range of baseline arteriolar velocity was similar in all groups
(control, 0.31-3.95 mm/s; nc-YSZ, 1.58-5.12 mm/s; PEEK,
0.96-2.65 mm/s; PEKK, 0.72-3.29 mm/s). Figure 3, A shows
that the implantation of nc-YSZ seems to initially evoke a
statistically significant increase in arteriolar velocity in comparison
with control. However, the arteriolar velocity declined in the
second week and reached a value comparable to control, PEEK,
and PEKK.
Velocity of a total of 46 venules was investigated for twoweeks
(control, n = 15; nc-YSZ, n = 14; PEEK, n = 7; PEKK, n = 10).
Range of baseline venular velocity was similar in all groups
(control, 0.49-5.04 mm/s; nc-YSZ, 0.31-4.21 mm/s; PEEK,
0.12-3.51 mm/s; PEKK, 0.12-0.72 mm/s). Figure 3, B shows
that during the first week, the venular velocity for animals with
PEEK and PEKK was decreased while it increased for control and
nc-YSZ. However, the difference in the venular velocity of all
groups during two weeks was not statistically significant.
Microhemodynamics: Microvascular flow
Figure 4 reveals that the changes in arteriolar and venular
flow in animals of all groups were not statistical significant. The
slight increase in arteriolar flow over time is due to anatomical
changes and vasodilation over two weeks. Therefore, data
indicated that the microvascular blood flow of animals was not
impaired by implantation of the materials.
Inflammation: Leukocyte-endothelial cell interaction
In each group, 30 venules were analyzed after two weeks.
Figure 5 demonstrated that nc-YSZ only induced a transient changein leukocyte endothelial cell interactions in venules of the host tissue
(17%) in comparison with the control (19%) after the first 15 days
of implantation, indicating a high degree of biocompatibility. The
lack of an inflammatory reaction to implants (no statistical
significance) indicated an adequate biocompatibility of nc-YSZ,
comparable to that of PEEK, PEKK and control hamsters.
Microvascular permeability
The macromolecular leakage was increased for all implant
groups with no statistical significance (Figure 6). For all groups,
the macromolecular leakage values were below 0.8-1, an intact
endothelial integrity can be assumed.31 Therefore, nc-YSZ did
not increase vascular permeability when compared to control and
commercial implants.Discussion
In this report, theDWCMwas used to study themicrocirculation
by means of intravital microscopy using transillumination.
Previously, this model proved to be ideal for the systematic in
vivo analysis of the host tissue interaction with biomaterials.18,19,32
Specifically, this model has been used to study the host tissue
response to cranioplasty biomaterials such as ceramic calcium
phosphate compounds20,21 and titanium.22,32,33
Conventionally-processed microcrystalline YSZ (mc-YSZ)
has well-proven biocompatibility in dental and orthopedic
applications.17 However, biocompatibility assessments for nc-YSZ
specifically are necessitated by the unique properties associated with
nanocrystallinity (e.g. increased surface energy). The prolonged
inflammatory response to an implant is one of the primary causes for
the failure to integrate into tissue.5
Figure 2 demonstrated that changes in arteriolar and venular
diameter in hamsters with nc-YSZ implant were not significantly
different than those of control and commercially available implants
(PEEK and PEKK). Significant vasodilation in the DWCMwould
be an initial sign of infection or acute inflammation.18 Figure 3
revealed a statistically significant increase in the arteriolar velocity
of hamsters with nc-YSZ implants in comparison with control in
week 1.However, byweek 2, this difference decreased and became
insignificant. Figure 4 shows insignificant difference between the
microvascular blood flowof all groups, indicating that implants did
not disturb the blood flow.
Figure 6. Macromolecule leakage as an indicator of microvascular permeability
in venules of striatedmuscle in hamster dorsal skinfold 15 days after control (no
implant) and implantation of nc-YSZ, PEEK, PEKK.N = 20 for each condition
and error bars represent 1 standard deviation.
1762 Y. Damestani et al / Nanomedicine: Nanotechnology, Biology, and Medicine 12 (2016) 1757–1763Analysis of microvascular permeability by quantifying the
extravasation of macromolecules, shown in Figure 6, indicated
that the endothelial lining of postcapillary and collecting venules
were not damaged as a result of nc-YSZ implantation.
Additionally, we have demonstrated the lack of activated
leukocytes in venules for all groups, indicating that the
nc-YSZ, PEEK, and PEKK did not induce an acute inflammatory
response in the host tissue. Thus, nc-YSZ exhibited a good
biocompatibility that was comparable to that of control, PEEK
and PEKK.
While PEEK and PEKK are FDA-approved commercially
available cranial implants, this is the first study, to the best of our
knowledge, to observe microhemodynamics changes in a hamster
backflap model in response to PEEK and PEKK implants. One
limitation of using the DWCM to study biomaterial reaction is that
this model cannot directly predict the bone ingrowth and response
around the implant. Comprehensive characterization of nc-YSZ as
a cranial material should be performed by combining the results of
this study with other models such as calvarial defect model.34
Future studies with nc-YSZ will include dynamic stimulus (e.g.
change in pCO2) to understand the effects of nc-YSZ cranial
implants on cerebral blood flow regulation.
In summary, this study demonstrated that nc-YSZ does not
impair microcirculation and endothelial integrity of striatedmuscle
in the DWCM. The nc-YSZ also did not result in enhanced
leukocyte activation and was as equally tissue-compatible as
commercial PEEK and PEKK cranioplasty materials. Clinically,
the results presented in this report indicate that nc-YSZ may
represent a good alternative for cranial implants.Acknowledgments
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